F. Ewald

发表

ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts.

C. Bokemeyer, J. Izbicki, Nicole Grabinski, 2015, Cellular signalling.

Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit.

F. Ewald, B. Nashan, A. Gulati, 2016, World journal of gastrointestinal surgery.

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma

M. Jücker, F. Ewald, A. Grottke, 2015, Journal of Cancer.

Evaluation of Periodontal Space Widening in Patients with Antiresorptive Drug-related Osteonecrosis of the Jaws (ARONJ) on Panoramic Radiographs

R. Friedrich, F. Ewald, R. Smeets, 2018, AntiCancer Research.

Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)—An In Vivo Animal Trial

M. O. Ahlers, M. Heiland, F. Ewald, 2021, International journal of molecular sciences.

Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors

M. Jücker, F. Ewald, A. Grottke, 2014, Investigational New Drugs.

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells

U. Schumacher, Nicole Grabinski, M. Jücker, 2012, Molecular Cancer.

High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

Henning Wege, T. Krech, A. Lohse, 2017, BMC Cancer.

Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4

Frank Höppner, Udo Schumacher, F. Höppner, 2016, PloS one.

A Critical Role of the IL-22–IL-22 Binding Protein Axis in Hepatocellular Carcinoma

J. Izbicki, P. Arck, F. Ewald, 2022, Cancers.

Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo

V. Mautner, M. Jücker, F. Ewald, 2020, International journal of molecular sciences.

Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

Nicole Grabinski, F. Ewald, 2014, Investigational New Drugs.

Discontinuing MEK inhibitors in tumor cells with an acquired resistance increases migration and invasion.

M. Jücker, F. Ewald, A. Grottke, 2015, Cellular signalling.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer

Christoph Wagener, Hartmut Schlüter, Sönke Harder, 2015, Molecular Cancer.

ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer

J. Izbicki, F. Ewald, C. Wagener, 2014, Clinical Cancer Research.

Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma

K. David, U. Schumacher, Nicole Grabinski, 2013, International journal of cancer.

Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo

T. Lange, U. Schumacher, S. Perner, 2023, Journal of Hematology & Oncology.

Extracellular-signal regulated kinase (Erk1/2), mitogen-activated protein kinase-activated protein kinase 2 (MK2) and tristetraprolin (TTP) comprehensively regulate injury-induced immediate early gene (IEG) response in in vitro liver organ culture.

M. Gaestel, D. Wirth, F. Ewald, 2016, Cellular signalling.

Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death

F. Ewald, T. Tamura, B. Nashan, 2016, Oncogene.

Ectopic Expression of Hematopoietic SHIP1 in Human Colorectal Cancer

G. Sauter, R. Simon, U. Schumacher, 2020, Biomedicines.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer

H. Schlüter, J. Izbicki, M. Jücker, 2015, Molecular Cancer.

Truncated O-GalNAc glycans impact on fundamental signaling pathways in pancreatic cancer.

M. Kwiatkowski, J. Izbicki, M. Jücker, 2021, Glycobiology.

High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

T. Krech, A. Lohse, F. Ewald, 2017, BMC Cancer.

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

T. Krech, K. Pantel, S. Riethdorf, 2017, Oncotarget.

Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).

F. Ewald, T. Tamura, B. Nashan, 2016, Cellular signalling.

Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)

H. Rohde, R. Friedrich, F. Ewald, 2020, Clinical Oral Investigations.

Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer

H. Schlüter, G. Sauter, R. Simon, 2020, Clinical & Experimental Metastasis.